Viatris: Drug Recall
Recall #D-0851-2021 · 08/23/2021
Class II: Risk
Recall Details
- Recall Number
- D-0851-2021
- Classification
- Class II
- Product Type
- Drug
- Recalling Firm
- Viatris
- Status
- Terminated
- Date Initiated
- 08/23/2021
- Location
- Morgantown, WV, United States
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 9,515 bottles
Reason for Recall
Failed Dissolution Specifications
Product Description
Lyrica CR (pregabalin) extended release tablets, 330 mg, 30-count bottles, Rx only, Distributed by Parke-Davis Division of Pfizer Inc., NY, NY 10017, NDC 0071-1029-01
Distribution Pattern
Nationwide within the United States
Other Recalls by Viatris
- Class III: Low Risk 09/13/2021
Data from FDA openFDA enforcement reports. This site is not affiliated with or endorsed by the FDA. Recall information may be updated by the FDA at any time.